Inactive Instrument
Finch Therapeutics Group, Inc. Stock
Stocks
FNCHQ
US31773D2009
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -1.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Blischak
CEO | Chief Executive Officer | - | 2023-05-15 |
Lance Thibault
DFI | Director of Finance/CFO | 60 | 2023-05-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Domenic Ferrante
BRD | Director/Board Member | 60 | 2019-09-24 |
Chris Shumway
CHM | Chairman | 60 | - |
Christian Lange
BRD | Director/Board Member | 46 | 2017-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/7/24 | Don | Director | 767 | 0.0478% | ||
| 5/20/24 | Don | Director | 3,750 | 0.2335% | ||
| 3/28/24 | Sell | Director | 8,242 | 0.5133% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.43% | +1.47% | - | - | 16.62M | ||
| -2.69% | -0.48% | +53.97% | +70.99% | 66.33B | ||
| -0.92% | +7.67% | +12.64% | +93.22% | 60.62B | ||
| 0.00% | +0.39% | +22.34% | +89.58% | 55.5B | ||
| +0.14% | +2.35% | +13.86% | +111.94% | 47.58B | ||
| -2.21% | -2.47% | +20.18% | +28.81% | 43.69B | ||
| -2.30% | -10.40% | +154.30% | +707.36% | 37.27B | ||
| +2.15% | +1.42% | +14.58% | +48.71% | 36.57B | ||
| -2.32% | -2.24% | +76.50% | +56.02% | 32.22B | ||
| +2.62% | +5.90% | -37.29% | +386.59% | 26.58B | ||
| Average | -0.70% | +0.05% | +36.79% | +177.02% | 45B | |
| Weighted average by Cap. | -0.83% | +0.20% | +36.63% | +152.92% |
Employees
1
















